MANAGEMENT OF ADVERSE EVENTS IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA TREATED WITH POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE: A POOLED SAFETY ANALYSIS OF 3 CLINICAL TRIALS

EHA Library, Philippe Moreau, 132833

MP0250, A BISPECIFIC VEGF- AND HGF-BLOCKING MULTI-DARPIN*, IN COMBINATION WITH BORTEZOMIB IN MULTIPLE MYELOMA: PRECLINICAL RATIONALE AND PHASE 2 STUDY OUTLINE

EHA Library, Michael Stumpp, 132834

CAN CAPILLARY ZONE ELECTROPHORESIS MONITOR DARWINIAN EVOLUTION OF MULTIPLE MYELOMA CLONES?

EHA Library, Pavel Kotoucek, 132835

THE CLINICAL COURSE OF RELAPSED OR REFRACTORY U.S. MULTIPLE MYELOMA (RRMM) PATIENTS RECEIVING TWO OR MORE LINES OF THERAPY

EHA Library, Dorothy Romanus, 132836

PRACTICE PATTERNS AND OUTCOMES IN ELDERLY U.S. PATIENTS WITH RELAPSED / REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Dorothy Romanus, 132837

COMPARISON OF FOUR NEUROPATHY ASSESSMENT SCALES IN EVALUATION OF TREATMENT EMERGENT NEUROPATHY IN NEWLY DIAGNOSED PATIENTS OF MULTIPLE MYELOMA TREATED WITH BORTEZOMIB BASED REGIMEN

EHA Library, Arjun Lakshman, 132838

SERUM B-CELL MATURATION ANTIGEN IS A BIOMARKER FOR PATIENTS WITH B-CELL DISORDERS

EHA Library, James Berenson, 132839

IMPACT OF IMMUNOPARESIS AND ALTERED SERUM FREE LIGHT CHAIN RATIO ON THE PROGRESSION OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) IN A DISTRICT GENERAL HOSPITAL IN UNITED KINGDOM.

EHA Library, Buddhika Badugama, 132840

OVERALL SURVIVAL IN PATIENTS WITH SYMPTOMATIC MULTIPLE MYELOMA IN THE REAL-WORLD SETTING: A RETROSPECTIVE ANALYSIS OF THE PHAROS REGISTRY IN THE NETHERLANDS

EHA Library, Silvia Verelst, 132841

COMPARISON BETWEEN 8-COLOR MULTIPARAMETER FLOW CYTOMETRY AND NEXT-GENERATION SEQUENCING TO DETECT MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA PATIENTS WHO UNDERWENT AUTO-SCT

EHA Library, HIROYUKI TAKAMATSU, 132842

RENAL AND HEMATOLOGIC OUTCOMES OF BORTEZOMIB-BASED TREATMENT IN PATIENTS WITH LIGHT CHAIN DEPOSITION DISEASE

EHA Library, Efstathios Kastritis, 132843

A POOLED ANALYSIS OF THE IMPACT OF AGE ON OUTCOMES IN PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA TREATED WITH POMALIDOMIDE + LOW-DOSE DEXAMETHASONE

EHA Library, Antonio Palumbo, 132844

PROSPECTIVE FUNCTIONAL GERIATRIC ASSESSMENT (CF-GA) IN MULTIPLE MYELOMA (MM) PATIENTS (PTS): CHANGES FROM BASELINE (T0) TO FOLLOW UP ASSESSMENT (T1)

EHA Library, Sandra Dold, 132845

IMPROVEMENT OF OVERALL SURVIVAL IN DANISH MULTIPLE MYELOMA PATIENTS AFTER 2008; A POPULATION-BASED STUDY FROM THE DANISH NATIONAL MULTIPLE MYELOMA REGISTRY

EHA Library, Niels Abildgaard, 132846

ASSESSING MYELOMA BONE DISEASE WITH WHOLE-BODY DIFFUSION-WEIGHTED MRI: COMPARISON WITH FDG PET-CT AND ASSESSMENT OF ADC VALUE

EHA Library, Kentaro Narita, 132847

IMPROTANCE CD138 IMMUNOSTAINING FOR ASSESSMENT OF BONE MARROW PLASMA CELL INFILTRATION IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Yoshiaki Usui, 132848

UPDATED RESULTS OF A SYSTEMATIC REVIEW OF THE RELATIVE EFFECTIVENESS OF TREATMENTS IN RELAPSED / REFRACTORY MULTIPLE MYELOMA

EHA Library, Áine Maguire, 132849

DURATION OF THERAPY IN U.S. PATIENTS TREATED FOR RELAPSED / REFRACTORY MULTIPLE MYELOMA (RRMM) IN THE REAL-WORLD

EHA Library, Dorothy Romanus, 132850

THE SERUM HEAVY/LIGHT CHAIN IMMUNOASSAY SERVES AS AN ADDITIONAL VALUABLE TOOL FOR SENSITIVE PARAPROTEIN ASSESSMENT, RISK STRATIFICATION AND DISEASE MONITORING IN PATIENTS WITH MONOCLONAL GAMMOPATHY

EHA Library, Christine Greil, 132851

ASSESSMENT OF FRAILTY IN A MULTIPLE MYELOMA (MM) SERIES

EHA Library, Eftychia Nikolaou, 132852

OVERALL RESPONSE RATE OF PATIENTS WITH REFRACTORY MULTIPLE MYELOMA TREATED WITH POMALIDOMIDE AND LOW DOSE DEXAMETHASONE AFTER LENALIDOMIDE FAILURE: INTERIM RESULTS OF THE POSEIDON STUDY

EHA Library, Tobias Dechow, 132853

IXAZOMIB PLUS LENALIDOMIDE-DEXAMETHASONE (IRD) VS PLACEBO-RD IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): CHINA CONTINUATION OF TOURMALINE-MM1

EHA Library, Jian Hou, 132854

PROSPECTIVE EVALUATION OF PROGNOSTIC AND PATHOPHYSIOLOGIC IMPLICATIONS OF BLOOD PRESSURE MONITORING AND BARORECEPTOR REFLEX SENSITIVITY (BRS) IN PATIENTS WITH AL AMYLOIDOSIS

EHA Library, Efstathios Kastritis, 132855

PREVALENCE AND PROGNOSTIC IMPACT OF OLIGOCLONAL BANDS IN PATIENTS WITH AL AMYLOIDOSIS

EHA Library, Luis Gerardo Rodríguez-Lobato, 132856

COMPARISON OF PERIPHERAL BLOOD STEM CELL (PBSC) MOBILIZATION WITH G-CSF ALONE VS G-CSF WITH CYCLOPHOSPHAMIDE POST VCD INDUCTION IN MULTIPLE MYELOMA

EHA Library, Chong Chyn Chua, 132857

ROLE OF PET/CT IN PROGNOSTICATING POST-TRANSPLANT OUTCOMES BASED ON A NEW SCORING SYSTEM: RESULTS OF PIPET-M TRIAL

EHA Library, Uday Yanamandra, 132858

THE EFFECT OF LEVEL OF RESPONSE TO TREATMENT ON ASSOCIATED COSTS AND HEALTHCARE RESOURCE UTILIZATION: A RETROSPECTIVE CHART REVIEW STUDY IN PATIENTS WITH SYMPTOMATIC MULTIPLE MYELOMA

EHA Library, Henri Leleu, 132859

SEVERE DECREASE OF BONE MATERIAL STRENGTH IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE PATIENTS DETECTED BY OSTEOPROBE® MICROINDENTATION METHOD.

EHA Library, Alba Gonzalez, 132860

REAL-WORLD PRESCRIBING PATTERNS IN U.S. MULTIPLE MYELOMA (MM) PATIENTS REFRACTORY TO LENALIDOMIDE IN THE FRONT-LINE

EHA Library, Mehul Jhaveri, 132861

DETERMINATION OF PROTHROMBOTIC PHENOTYPE IN PATIENTS WITH MULTIPLE MYELOMA ON IMMUNOMODULATORY THERAPY BY THE CALIBRATED AUTOMATED THROMBOGRAM.

EHA Library, Veronika Shmeleva, 132862

IN MULTIPLE MYELOMA, T REGULATORY CELLS ARE SIGNIFICANTLY REDUCED AFTER TREATMENT WITH LENALIDOMIDE BUT NOT BORTEZOMIB AND CORRELATE WITH THE ACHIEVEMENT OF AT LEAST VERY GOOD PARTIAL RESPONSE

EHA Library, Christina Hadjiaggelidou, 132863

THE IMPACT OF THE TYPE OF MYELOMA-DEFINING EVENT ON EARLY MORTALITY AND SURVIVAL

EHA Library, Rafael Rios-Tamayo, 132864

REVLIMID, BENDAMUSTINE AND PREDNISOLONE (RBP) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: FINAL RESULTS OF A PHASE II CLINICAL TRIAL; OSHO – #077

EHA Library, Juliane Beck, 132865

BETTER OUTCOME IN AL AMYLOIDOSIS (ALA) TREATED WITH MULTIPLE MYELOMA-ORIENTED REGIMENS COMPARED WITH CYCLOPHOSPHAMIDE/BORTEZOMIB/DEXAMETHASONE (CYBORD) IN A SINGLE CENTER EXPERIENCE

EHA Library, ANGELO BELOTTI, 132866

PROGNOSTIC SIGNIFICANCE OF THE REVISED INTERNATIONAL STAGING SYSTEM IN MULTIPLE MYELOMA

EHA Library, Jelena Bila, 132867

SHORT SYSTEMIC TREATMENT CONCURRENT WITH INTENSITY-MODULATED RADIOTHERAPY BY TOMOTHERAPY (IMRT) SHOWS IMPROVEMENT OF PROGRESSION-FREE SURVIVAL IN SOLITARY PLASMACYTOMA OF THE BONE (SPB)

EHA Library, Emmanuelle Le Ray, 132868

POLYCLONAL SERUM IGM AS A PROGNOSTIC MARKER IN NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Mariasanta Napolitano, 132869

NEW IMWG COMPARED TO CRAB CRITERIA TO PROPERLY DEFINE START-TIME THERAPY IN MULTIPLE MYELOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS OF 180 PATIENTS

EHA Library, Lorenza Torti, 132870

SPECIAL IMMUNE SIGNATURE OF MM PATIENTS IN LONG TERM COMPLETE RESPONSE (LTCR) WITH NEGATIVE MINIMAL RESIDUAL DISEASE (MRD) AFTER AUTOLOGOUS TRANSPLANT (ASCT): A SINGLE CENTRE EXPERIENCE

EHA Library, Beatriz Aguado Bueno, 132871

DURATION OF SECOND LINE TREATMENT AND SURVIVAL IN MULTIPLE MYELOMA

EHA Library, Hari Parameswaran, 132872

AGE-RELATED HEALTHCARE DISPARITIES IN MULTIPLE MYELOMA

EHA Library, Mathieu Puyade, 132873

THE FIRST TRIAL: ANALYSIS OF THE ASIAN SUBGROUP OF TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH CONTINUOUS LENALIDOMIDE AND LOW-DOSE DEXAMETHASONE

EHA Library, Jin Lu, 132874

DIAGNOSTICS AND PROGNOSTIC STRATIFICATION OF PATIENTS WITH WALDENSTRÖM’S MACROGLOBULINEMIA – SINGLE CENTRE EXPERIENCE

EHA Library, Lenka Krupkova, 132875

DESCRIPTION OF PATIENT CHARACTERISTICS, TREATMENT PATTERNS AND RESOURCE USE FOR PATIENTS WITH MULTIPLE MYELOMA TREATED IN THREE LOCAL HEALTH UNITS (LHUS) IN ITALY

EHA Library, Sumeet Panjabi, 132876

OUTCOMES FOR ASIAN PATIENTS WITH RELAPSED MULTIPLE MYELOMA TREATED WITH CARFILZOMIB AND DEXAMETHASONE VS BORTEZOMIB AND DEXAMETHASONE: A SUBGROUP ANALYSIS OF THE PHASE 3 ENDEAVOR STUDY (NCT01568866)

EHA Library, Jae Hoon Lee, 132877

THE PROGNOSTIC SIGNIFICANCE OF DEL1P IN MULTIPLE MYELOMA PATIENTS.

EHA Library, Antoniya Nedeva, 132878

PEGFILGRASTIM VERSUS FILGRASTIM IN THE MANAGEMENT OF POST-CHEMOTHERAPY NEUTROPENIA IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA IN TREATMENT WITH BVD (BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE)

EHA Library, Claudio Cerchione, 132879

MOLECULAR CHARACTERIZATION OF MYELOPROLIFERATIVE NEOPLASMS WITH CONCOMITANT BCR-ABL1 AND JAK2 V617F OR CALRETICULIN MUTATIONS

EHA Library, Csaba Bödör, 132880

ABNORMAL EXPRESSION OF LCN2 (NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN) IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Tiziana Fanelli, 132881

FACS SORTED PERIPHERAL BLOOD CELLS IDENTIFY CALR MUTATIONS IN B-AND T CELLS

EHA Library, Lasse Kjær, 132882

FAILURE OF MEGAKARYOCYTE APOPTOSIS IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Jacques Malherbe, 132883

INCREASED PLASMA NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) IS ASSOCIATED WITH A HYPERPROLIFERATIVE PHENOTYPE AND RESTRAINS DISEASE PROGRESSION IN MPN-ASSOCIATED MYELOFIBROSIS

EHA Library, Vittorio Rosti, 132884

DOES THE MUTATIONAL STATUS AFFECT THE BONE MARROW MORPHOLOGICAL DATA IN PATIENTS WITH CLASSICAL PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS?

EHA Library, Jose Maria Raya, 132885

HDAC INHIBITION SYNERGIZES WITH ANTIOXIDANT THERAPY TO TARGET MYELOPROLIFERATIVE NEOPLASMS

EHA Library, António M Almeida, 132886

REDUCED FREQUENCY OF CIRCULATING CD4+CD25+CD127LOWFOXP3+ REGULATORY T CELLS IN PRIMARY MYELOFIBROSIS

EHA Library, Giovanni Barosi, 132887

IMPACT OF SPLENOMEGALY ON MPN SYMPTOMS AND ASSOCIATION WITH CLINICAL FEATURES: AN ANALYSIS BY THE MPN QUALITY OF LIFE INTERNATIONAL STUDY GROUP

EHA Library, Holly L Geyer, 132888

ANALYSIS OF CLINICAL PHENOTYPE AND OUTCOME IN CALR VERSUS JAK2 MUTATED OR TRIPLE-NEGATIVE ESSENTIAL THROMBOCYTEMIA

EHA Library, Andrea Aroldi, 132889

A MULTICENTER EVALUATION OF THE REVISED 2015 WHO MINOR CRITERIA FOR PREFIBROTIC PRIMARY MYELOFIBROSIS

EHA Library, Georg Jeryczynski, 132890

THE MEGAKARYOCYTIC INDEX:A NEW TOOL FOR THE DIAGNOSIS OF ESSENTIAL THROMBOCYTHEMIA

EHA Library, Maria Luigia Randi, 132891

MOLECULAR CHARACTERIZATION OF ESSENTIAL THROMBOCYTHEMIA PATIENTS EVOLVED TO POLYCYTHEMIA VERA

EHA Library, Carlos Besses, 132892

PALPITATIONS AND ARRHYTHMIA IN 3649 HIGH-RISK PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA: RESULTS FROM THE PROSPECTIVE LONG-TERM OBSERVATIONAL EXELS STUDY

EHA Library, Luigi Gugliotta, 132893

SYMPTOMS, RISK CLASSIFICATION, AND SPLEEN SIZE IN JAK2 INHIBITOR-NAÏVE MYELOFIBROSIS: IMPLICATIONS FOR JAK2 INHIBITOR TREATMENT

EHA Library, Robyn Scheber, 132894

OSTEOPROTEGERIN (OPG) AND INTERLEUKIN-8 (IL-8) IMMUNOSTAINING IN BONE MARROW (BM) BIOPSIES OF PATIENTS WITH PH-NEGATIVE MYELOPROLIFERATIVE DISORDERS (MPD) AT DIAGNOSIS: CLINICAL CORRELATIONS

EHA Library, Diana Triantafyllopoulou, 132895

MYELOPROLIFERATIVE NEOPLASMS AND THROMBOSIS: A DANISH COHORT STUDY

EHA Library, Inger Lise Gade, 132896

PROCOAGULANT MICROPARTICLE IS A NEW SURROGATE BIOMARKER FOR THROMBOTIC EVENTS IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS.

EHA Library, Yasuhiro Taniguchi, 132897

SPLENOMEGALY AND ELEVATED ALKALINE PHOSPHATASE ARE STRONG AND INDEPENDENTADVERSE PROGNOSTIC MARKERS IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS

EHA Library, Mohamad Jawhar, 132898

DEFERASIROX IN THE TREATMENT OF IRON OVERLOAD DURING MYELOPROLIFERATIVE NEOPLASMS (MPN)

EHA Library, Raffaele Porrini, 132899

CLINICAL FEATURES OF DIFFERENT GENOTYPES IN A COHORT OF 172 PATIENTS WITH CALRETICULIN-MUTATED ESSENTIAL THROMBOCYTHEMIA

EHA Library, Valerio De Stefano, 132900

GERMLINE VARIATIONS AT JAK2 AND TERT ARE ASSOCIATED WITH MYELOPROLIFERATIVE NEOPLASMS IN TAIWANESE POPULATION

EHA Library, Yi-Hao Chiang, 132901

MORPHOLOGIC DYSPLASIA IS ASSOCIATED WITH A MORE AGGRESSIVE DISEASE PHENOTYPE IN MYELOFIBROSIS

EHA Library, Michael Byrne, 132902

PROPOSAL FOR A REVISED PROGNOSTIC MODEL IN PRIMARY MYELOFIBROSIS THAT ACCOUNTS FOR JAK2, MPL AND CALR MUTATIONS ：AN EXPERIENCE OF A SINGLE CENTER IN CHINA

EHA Library, Bing Li, 132903

INCREASED RISK OF AGE-RELATED MACULAR DEGENERATION IN PATIENTS WITH PHILADELPHIA-NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Marie Bak, 132904

IMPACT OF JAK2 AND CALR MUTATIONS ON THE DISEASE FEATURES AND OUTCOME AMONG PATIENTS WITH PRIMARY MYELOFIBROSIS OR ESSENTIAL THROMBOCYTHEMIA TREATED WITH STANDARD OF CARE (INCLUDING RUXOLITINIB)

EHA Library, Valerie Hupfer, 132905

JAK2 AND CALR MUTATION STATUS DEFINES SUBTYPES OF ESSENCIAL THROMBOCYTHEMIA WITH SUBSTANTIALLY DIFFERENT CLINICAL COURSE

EHA Library, Mafalda Alpoim Vieira, 132906

THROMBOSIS IN MYELOPROLIFERATIVE NEOPLASIA ASSOCIATED WITH DIFFERENT COAGULATION FACTOR POLYMORPHISMS

EHA Library, Ruta Dambrauskiene, 132907

A PHASE 1 OPEN LABEL STUDY TO DETERMINE THE PHARMACOKINETICS OF PACRITINIB IN PATIENTS WITH MILD TO SEVERE RENAL IMPAIRMENT AND END STAGE RENAL DISEASE (ESRD) COMPARED WITH HEALTHY SUBJECTS

EHA Library, Suliman Al-Fayoumi, 132908

RUXOLITINIB TREATMENT FOLLOWING INTERFERON IN PATIENTS WITH POLYCYTHEMIA VERA: AN ANALYSIS FROM THE RESPONSE TRIAL

EHA Library, Jean-Jacques Kiladjian, 132909

DEVELOPMENT OF AN MF PATIENT REPORTED OUTCOME (PRO) TOOL FOR FDA QUALIFICATION: COMPREHENSIVE LITERATURE SEARCH AND PHYSICIAN COGNITIVE DEBRIEFING RESULTS

EHA Library, Holly L Geyer, 132910

STUDY OF ADHERENCE RATES AND SIDE EFFECTS OF ORAL TREATMENTS IN POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTEMIA (OUEST STUDY)

EHA Library, Ronan LE CALLOCH, 132911

ERYTHROPOIESIS-STIMULATING AGENTS (ESA) FOR ANEMIA IN MYELOFIBROSIS (MF): A REAL LIFE EXPERIENCE ON 31 UNSELECTED PATIENTS.

EHA Library, Marco Cerrano, 132912

A RETROSPECTIVE COHORT STUDY REPORTING ON THE DISEASE CHARACTERISTICS AND OUTCOMES OF PATIENTS DIAGNOSED UNDER THE AGE OF 50 YEARS WITH PRIMARY OR SECONDARY MYELOFIBROSIS

EHA Library, Samah Alimam, 132913

USEFULNESS OF PERFORMING JAK2 MUTATIONAL ANALYSIS IN PATIENTS WITH MODERATE ABSOLUTE ERYTHROCYTOSIS

EHA Library, Elisa Roncoroni, 132914

PROGNOSIS FACTORS CONDITIONING THE RISK OF MIELOFIBROTIC TRANSFORMATION IN ESSENTIAL THROMBOCYTHEMIA: SIGNIFICANCE OF ALLELIC BURDEN AND THE NUMBER OF LEUCOCYTES AT DIAGNOSIS IN YOUNG PATIENTS.

EHA Library, Maria Isabel Montero, 132916

ACTIVATED STAT5 DRIVES PERIPHERAL T CELL LYMPHOMAS

EHA Library, Barbara Maurer, 132918

MECHANISM, CONSEQUENCES AND THERAPEUTIC TARGETING OF ABNORMAL IL-15 SIGNALING IN CUTANEOUS T-CELL LYMPHOMA.

EHA Library, Anjali Mishra, 132919

EXOME SEQUENCING REVEALS RECURRENT GERMLINE VARIANTS IN PATIENTS WITH FAMILIAL LYMPHOPLASMACYTIC LYMPHOMA.

EHA Library, Aldo Roccaro, 132920

COMBINATION OF THE GLYCOENGINEERED TYPE II CD20 ANTIBODY OBINUTUZUMAB WITH THE NOVEL BCL-2 SELECTIVE INHIBITOR VENETOCLAX INDUCES ROBUST CELL DEATH IN NHL MODELS AND CLL PATIENT SAMPLES

EHA Library, Deepak Sampath, 132921

THE CD47-BLOCKING CANCER IMMUNOTHERAPEUTIC TTI-621 HAS ANTI-TUMOR EFFECTS ACROSS A BROAD RANGE OF HEMATOLOGICAL MALIGNANCIES

EHA Library, Robert A Uger, 132922

ACTIVATION OF MTORC2 COMPLEX CONTRIBUTES TO CELL CYCLE PROGRESSION AND SURVIVAL IN ALK+ ANAPLASTIC LARGE CELL LYMPHOMA

EHA Library, George Rassidakis, 132923

SEARCHING FOR NOVEL PROGNOSTIC BIOMARKERS IN DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) BY CIBERSORT-BASED ANALYSIS OF TUMOR MICROENVIRONMENT.

EHA Library, Sabino Ciavarella, 132924

MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF ALK+ AND ALK- ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)-DERIVED EXOSOMES AND THEIR INTERACTIONS WITH TUMOR MICROENVIRONMENT

EHA Library, George Rassidakis, 132925

A 6-GENE EXPRESSION SIGNATURE IN MANTLE CELL LYMPHOMA: RESULTS FROM THE FONDAZIONE ITALIANA LINFOMI (FIL)-MCL-0208 TRIAL

EHA Library, Riccardo Bomben, 132926

BONE MARROW MESENCHYMAL STEM/STROMAL CELLS FROM SPLENIC MARGINAL ZONE LYMPHOMA PATIENTS SHOW DISTINCT INTRINSIC CHARACTERISTICS AND EFFECTS ON B-LYMPHOCYTE CHEMOTAXIS AND APOPTOSIS

EHA Library, Charalampos Pontikoglou, 132927

INTERRUPTION OF CCL20-CCR6 INTERACTION INHIBITS METASTASIS OF ADVANCED CUTANEOUS T-CELL LYMPHOMA

EHA Library, Hiroyuki Tagawa, 132928

TUMOR GENE EXPRESSION PROFILES ASSOCIATED WITH SINGLE-AGENT COPANLISIB ACTIVITY IN HEAVILY PRETREATED PATIENTS WITH INDOLENT AND AGGRESSIVE NON-HODGKIN LYMPHOMA (NHL)

EHA Library, Li Liu, 132929

PROGNOSTIC IMPACT, PHENOTYPIC AND MOLECULAR CHARACTERIZATION OF CONCORDANT AND DISCORDANT BONE MARROW INVOLVEMENT IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Miguel Alcoceba, 132930

MULTIPLE NF-KB INDUCERS PROMOTE C-MYC-DEPENDENT B-CELL LYMPHOMAGENESIS.

EHA Library, Nicolas Arnaud, 132931

PROGRAMMED CELL DEATH 1 EXPRESSION IS ASSOCIATED WITH INFERIOR SURVIVAL IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Shin Young Hyun, 132932

ARGINASE 1 IS A MARKER OF MYELOID-MEDIATED IMMUNOSUPPRESSION WITH PROGNOSTIC MEANING IN CLASSIC HODGKIN’S LYMPHOMA

EHA Library, ALESSANDRA ROMANO, 132933

A NOVEL DIGITAL PCR ASSAY FOR MYD88 L265P MUTATION DETECTION IN WALDENSTRÖM MACROGLOBULINEMIA: MINIMAL RESIDUAL DISEASE MONITORING AND CHARACTERIZATION ON CIRCULATING FREE DNA

EHA Library, Daniela Drandi, 132934